52W Range | $0.20-$13.55 |
Market Cap | $9.8M |
Shares Short | 322,582 |
Revenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.66 |
CEO | Mr. Ilan Hadar M.B.A. |
CFO | Ms. Mirit Horenshtein Hadar |
Address | The Goldyne Savad Institute of Gene Therapy, Jerusalem, Israel, 9112001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |